← FDA Drug Approvals (Drugs@FDA)
EPLERENONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ADAPTIS · Approved 2020-08-10
Drug application
- FDA Application #
ANDA212765- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EPLERENONE
- Generic name
- Eplerenone
- Active ingredients
- EPLERENONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ADAPTIS
- First approval
- 2020-08-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown